OPTHOptimi Health Corp. Common Shares

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · optimihealth.ca

5.000USD+5.71%Mkt Cap: 28.63M $P/E: —3d ago

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$65.19BUSDP/E 23.7

TAK

Takeda Pharmaceutical Co. Ltd.

$58.06BUSD

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$43.98BUSDP/E 20.4

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation

Swedish Orphan Biovitrum AB

Neurocrine Biosciences, Inc.

$15.51BUSDP/E 22.3

ELAN

Elanco Animal Health Incorporat

$11.98BUSD

RDY

Dr. Reddy's Laboratories Ltd

Hims & Hers Health, Inc.

$7.88BUSD

LNTH

Lantheus Holdings Inc

$6.53BUSDP/E 23.9

AMRX

Amneal Pharmaceuticals, Inc. Class A

Kiniksa Pharmaceuticals, Ltd.

$6.08BUSDP/E 79.8

Key Statistics

Company

Market Cap28.63M $

Enterprise Value13.00M $

Revenue (TTM)175.67K $

Gross Profit-68.13K $

Net Income (TTM)-3.71M $

Revenue/Share0.0500 USD

Last Price5.000 USD

Fiscal Year EndSep 2025

MR QuarterJun 2026

Employees—

CountryUS

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-3.22

EV/Revenue73.98

P/S158.73

P/B6.18

EPS (TTM)-1.49

EPS (Forward)—

52W Range

4.00042% of range6.400

52W High6.400 USD

52W Low4.000 USD

Profitability

Gross Margin-15.98%

Oper. Margin-957.82%

EBITDA Margin0.00%

Profit Margin-870.75%

ROE-56.49%

ROA-24.40%

Growth

Revenue Growth-28.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-2.63M $

CapEx (TTM)88.38K $

FCF Margin-890.48%

FCF Yield-5.46%

Net Debt-7.93M $

Net Debt/EBITDA1.96

Balance Sheet

Debt/Equity0.99

Current Ratio1.73

Quick Ratio1.62

Book Value/Sh0.7876 USD

Cash/Share3.043 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.5.73M

Float3.49M

Insiders12.66%

Institutions7.75%

Short Interest

Short Ratio0.3d

Short % Out.0.36%

Shares Short72.20K

Short (prev mo.)66.00K

Technical

SMA 504.673 (+7.0%)

SMA 2004.869 (+2.7%)

Beta—

S&P 52W Chg18.16%

Avg Vol (30d)156.21K

Avg Vol (10d)26.45K

Technical Indicators

RSI (14)55.2

MACD0.0188

MACD Signal0.0116

MACD Hist.+0.0072

BB Upper5.107 USD

BB Middle4.840 USD

BB Lower4.574 USD

BB Width11.01%

ATR (14)0.3064 USD

Vol Ratio (20d)1.02x